The Global Serological Test for Influenza Disease Diagnostics Market was valued at USD 8.9 billion in 2023 and is projected to reach a market size of USD20.51 billion by 2030. Over the forecast period of 2024-2030, market is projected to grow at a CAGR of 12.6%.
When seasonal influenza A and B viruses are circulating in the surrounding population during accelerated influenza activity, testing for the influenza virus is no longer necessary to determine the medical prognosis of influenza in outpatients with suspected influenza. On the other hand, influenza virus testing can help clinical management when the results may affect clinical decisions about starting antiviral medication, using other diagnostic tests, or enforcing contamination prevention and influenza manipulation measures. It is no longer recommended to use serological testing for influenza when making medical decisions. Serological testing results for antibodies to influenza A or B viruses on a single serum sample cannot be properly interpreted, although being offered by certain commercial laboratories. A 4-fold or more elevation in influenza virus strain-specific antibodies can be detected by reliable testing at a small number of public fitness or research laboratories using matched acute and convalescent samples collected two to three weeks apart. Consequently, serological testing for influenza is no longer recommended for anything other than research and public health studies, and it no longer yields prompt results to aid in clinical decision-making.
Key Market Insights:
Multiplex assays, which can identify influenza as well as other respiratory viruses like COVID-19, are becoming more and more popular in hospitals, while PCR testing are still the gold standard for quickly diagnosing influenza. This demonstrates the increasing desire for more comprehensive diagnostic tools that increase effectiveness and resource efficiency.Due to the growing need for quick and decentralised testing, especially in primary care settings and for possible home usage, the global market for CLIA-waived point-of-care influenza diagnostics is anticipated to increase significantly. According to estimates from the World Health Organisation (WHO), there are around 1 billion cases of seasonal influenza worldwide each year. Serological assays can be extremely important in increasing access to influenza diagnostics in settings with low resources because of their possible cost-effectiveness when compared to certain other techniques. Even with recent advances, serological testing can occasionally yield unreliable findings, particularly in the early stages of illness. The necessity of developing serological tests further to increase their specificity and sensitivity for identifying influenza A and B strains.
Global Serological Test for Influenza Disease Diagnostics Market Drivers:
Increasing Influenza Rate and the Requirement for Easily Accessible Diagnostics
An ever-increasing illness burden presents a daunting challenge to the worldwide influenza epidemic. Influenza viruses spread mostly due to factors like population expansion and the world's growing interconnection via international travel. To properly detect and treat influenza, there must always be an adequate supply of diagnostic instruments due to its unrelenting growth. In this case, serological testing becomes an invaluable tool, especially in areas where access to cutting-edge technology is restricted. In contrast to certain diagnostic techniques that need specific tools and lab environments, serological testing provides a more convenient option. In environments with low resources, where specialised diagnostic infrastructure may be hard to come by, this accessibility is essential. Serological testing can be extremely helpful in preventing the spread of influenza and guaranteeing prompt treatment for individuals who become ill by offering a trustworthy diagnostic alternative in these areas.
Diagnostic Tests using Serology for Influenza in Developing Areas
The World Health Organisation estimates that there are an astounding 1 billion cases of seasonal influenza worldwide each year, making the burden of influenza a serious public health problem. Developing nations are disproportionately affected by this cost because they frequently lack the capacity to get cutting-edge diagnostic equipment. In this instance, serological testing provides a glimmer of optimism in the battle against influenza. Due to their inherent cost-effectiveness, serological assays have enormous potential to increase access to influenza diagnostics in these settings. Serological tests are less expensive to design and administer than certain other diagnostic techniques that need specialised facilities and costly equipment. In environments with low resources, where healthcare budgets are frequently squeezed, this affordability element is critical. Serological tests have the potential to empower healthcare professionals by facilitating faster identification of influenza infections, so enabling early treatment and perhaps halting the spread of epidemics. Apart from that, the possibility of creating point-of-care versions of serological tests increases their availability in areas with inadequate laboratory facilities. In conclusion, because serological tests are more affordable and have the potential to be used more widely, they can close the diagnosis gap in poor countries, resulting in better public health outcomes and more efficient management of influenza.
Global Serological Test for Influenza Disease Diagnostics Market Restraints and Challenges:
The global market for serological tests for influenza disease diagnostics has prospects, but there are also obstacles that must be overcome. Accuracy assurance is a major obstacle. Results from serological testing might be erroneous, particularly in the early stages of an illness when antibody levels are low. Inappropriate therapy and misdiagnosis may result from this. There are also restrictions on strain specificity. Certain influenza strains may be difficult for current testing to distinguish from one another, especially novel variations. This may impede precise diagnosis and make public health initiatives more difficult. Additionally, serological tests are less useful in circumstances needing quick findings since they are surpassed in speed and accuracy by more certain techniques like as PCR testing. It can be challenging to get insurance payment for serological tests, particularly for at-home testing, which may restrict certain patients' accessibility and affordability. For serological tests to reach their full potential and be more widely used in the worldwide influenza diagnostics industry, these obstacles must be overcome.
Global Serological Test for Influenza Disease Diagnostics Market Opportunities:
Prospective prospects exist for the future in the global market for serological tests for influenza disease diagnostics. First off, widespread at-home influenza testing may become possible with the development of more straightforward and user-friendly serological assays. This might potentially lessen the severity of sickness and its transmission rates by enabling people to receive a diagnosis and start treatment more quickly. Second, there is a great chance to develop serological tests that can identify a wider variety of influenza strains, including novel and developing variations. For influenza monitoring, this increased strain coverage would be important, improving public health readiness to fend against seasonal flu and possible pandemics. Lastly, significant progress towards developing serological assays capable of differentiating between an ongoing influenza illness and prior exposure would be transformative.
SEROLOGICAL TEST FOR INFLUENZA DISEASE DIAGNOSTICS MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 - 2030 |
|
Base Year |
2023 |
|
Forecast Period |
2024 - 2030 |
|
CAGR |
12.6% |
|
Segments Covered |
By Influenza Type, End-Use, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
altona Diagnostics GmbH, Becton, bioMérieux SA, Coris BioConcept SPRL, DiaSorin SA, Dickinson and Company, ELITech Group, GenMark Diagnostics, Inc., Genome Diagnostics, Pvt. Ltd., Hologic, Inc. |
Type A
Type B
Type C
According to the kind of influenza, in 2022 kind A influenza caused the most problems and spread the fastest. This virus is to blame for the global spread of a new illness and flu pandemics. Additionally, influenza A has been the primary cause of most epidemics, which are large-scale outbreaks of an infectious disease within a community at a certain period.
Hospitals
POCT
Laboratories
The hospital category had the largest income share based on End-Use. Hospitalisation rates associated with seasonal influenza are high. The hospital stays demonstrate the disease's manageable severity. Because influenza can also exacerbate current fitness requirements or cause other issues that require hospitalisation. 40.6% of patients experienced pregnancy difficulties, 44% had cardiovascular disorders, and 44% had hypertension issues. Growing underlying clinical issues such autoimmune illnesses force patients to seek treatment at health centres. Advancements in technology are expected to simplify the monitoring process for the elderly population, particularly regarding the development of more advanced flu diagnostic tests and the combination of POCT and flu testing. POCT is also expected to increase flu testing in Asia Pacific countries' remote areas, where access to healthcare is scarce.
North America
Asia-Pacific
Europe
South America
Middle East and Africa
North America is regarded as the important region geographically and accounted for most of the income share. Over the course of the projection period, it is expected that the area will continue to play a prominent role. This growth can be linked to the presence of important actors as well as the expansion of government monitoring. Asia Pacific, mostly driven by China and India, has the fastest CAGR throughout the projected timeframe. The main factors contributing to the rise in the area are the large number of impacted individuals, the improvement of government cooperation, and the advancement of healthcare facilities. To address the issues, some South-East Asia-Pacific nations have teamed up with international organisations like the WHO. The most common issue encountered in the field is the shortage of flu-positive specimens.
COVID-19 Impact Analysis on the Global Serological Test for Influenza Disease Diagnostics Market:
The COVID-19 pandemic has had a significant negative influence on the serological test for influenza disease diagnostics market. The pandemic has altered the global medical care delivery system. The COVID-19 pandemic has had a significant impact on the influenza diagnostics industry. Unfavourable changes to regulations and policies, the shutdown of production facilities owing to lockdowns, and supply chain disruptions have all negatively impacted the market's expansion. The availability of influenza diagnostics products to end users has also declined because of restricted operations in the majority of businesses, inadequate support for research and instructional institutes, and difficulties in delivering necessary/post-sales offers because of lockdowns. Moreover, influenza and COVID-19 have many characteristics; both seasonal flu viruses (A and B) and COVID-19 are communicable and present with identical respiratory disease symptoms. Epidemics of influenza often occur around December through February. The COVID-19 pandemic also occurred during flu season, which led to a rise in the use of influenza tests at this time. The COVID-19 pandemic has recently made the issue more critical. Flu testing has significantly increased across the United States. Patients continue to report confusing COVID-19 with the flu since these first symptoms are quite identical. The two viruses' corresponding fatality quotes and sequential intervals, however, differ. Due to the outbreak, rapid influenza diagnostic testing has increased in tandem with COVID-19 tests. The industry is expected to soar after advancements in point-of-care technology that combines influenza A and B testing with COVID-19 testing.
Recent Trends and Developments in the Global Serological Test for Influenza Disease Diagnostics Market:
Alongside the wider area of influenza diagnostics, the worldwide market for serological tests is also changing. The emergence of multiplex assays, such as the BD Veritor Plus System, which can detect respiratory viruses like COVID-19 in addition to influenza A and B, is one significant trend. Because of its effectiveness and capacity to identify a broader spectrum of disorders with a single test, this combination testing technique is becoming more and more common. There's also an increasing focus on creating point-of-care diagnostics that qualify for CLIA waivers. Without relying on centralised laboratories, these streamlined tests may be utilised at home or in doctor's offices to get speedier results. Furthermore, technological developments such as smaller devices and better immunoassay formats might lead to faster, more accurate, and more user-friendly influenza serological testing.
Key Players:
altona Diagnostics GmbH
Becton
bioMérieux SA
Coris BioConcept SPRL
DiaSorin SA
Dickinson and Company
ELITech Group
GenMark Diagnostics, Inc.
Genome Diagnostics, Pvt. Ltd.
Hologic, Inc.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The Global Serological Test for Influenza Disease Diagnostics Market size is valued at USD 8.9 billion in 2023.
The worldwide Global Serological Test for Influenza Disease Diagnostics Market growth is estimated to be 12.6% from 2024 to 2030.
It is anticipated that serological tests for influenza diagnostics would witness improvements in home testing, increased coverage of strains, and enhanced capacity to differentiate between illnesses from the past and present.
The worldwide market for serological tests for influenza disease diagnostics has been affected by the COVID-19 pandemic in several ways. On the one hand, there is a greater need for diagnostic tests of all types, including influenza testing, because of the increased attention on infectious illnesses. However, the COVID-19 test's competitiveness and supply chain problems hindered the influenza diagnostics market's expansion.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
